Report

Innovations in Service Delivery in the Age of Genomics. Workshop Summary

Released:: May 13, 2009
Type:: Workshop Summary
Topic:: Biomedical and Health Research
Activity:: Roundtable on Translating Genomic-Based Research for Health
Board:: Board on Health Sciences Policy

Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.

New discoveries in genomics - that is, the study of the entire human genome - are changing how we diagnose and treat diseases. Whereas previously, genetic testing could only screen for rare genetic disorders, increasingly, patients and their physicians are able to use genetic information to predict the risk of common diseases such as diabetes and breast cancer and to help determine prevention and treatment options. Genetic specialists have long been the main providers of genetic services, offering intensive counseling for rare genetic disorders. However, as the trend shifts from genetic testing largely being undertaken for rare genetic disorders to, increasingly, individuals being screened for common diseases, general practitioners, pediatricians, obstetricians/gynecologists, and other providers need to be knowledgeable about and comfortable using genetic information to improve their patients' health.

The Roundtable on Translating Genomic-Based Research for Health held the public workshop "Innovations in Service Delivery in the Age of Genomics" on July 27, 2008. The workshop set out to examine the current system of genetic service delivery, learn about some pioneering current practice models, and propose new models for integrating genetic and genomic innovations into education, training, and clinical practice. Participants discussed the strengths and challenges of the current system and considered a vision for the future of genetic and genomic services, which may not be so distant after all.

Reports of Interest

Barriers to Integrating Crisis Standards of Care Principles into... Released: January 23, 2012
Sex-Specific Reporting of Scientific Research - Workshop Summary Released: January 13, 2012
Strengthening a Workforce for Innovative Regulatory Science in... Released: December 21, 2011

Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity Released: December 15, 2011
Integrating Large-Scale Genomic Information into Clinical Practice -... Released: November 11, 2011
Facilitating Collaborations to Develop Combination Investigational Cancer... Released: October 31, 2011

Public Engagement and Clinical Trials: New Models and Disruptive... Released: October 14, 2011
Patients Charting the Course: Citizen Engagement in the Learning Health... Released: October 3, 2011
Prepositioning Antibiotics for Anthrax Released: September 30, 2011

back

Other Reports by this Activity

Displaying: 3 of 7 Reports

Integrating Large-Scale Genomic Information into Clinical Practice - Workshop Summary As the technology and affordability of genomic sequencing continues to evolve and the clinical applications for genomics-based research increase, it is important to address how genomics data can best be integrated into the clinical setting. On July 19, 2011, the IOM’s Roundtable on Translating Genomic-Based Research for Health hosted a workshop to highlight and identify the challenges and opportunities in integrating large-scale genomic information into clinical practice. Challenges for realizing genomic medicine range from the analysis, interpretation, and delivery of genetic information to associated workforce, ethical, and legal issues.
Released: November 11, 2011
Generating Evidence for Genomic Diagnostic Test Development – Workshop Summary Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person’s response to certain drugs, estimate the risk of developing Alzheimer’s disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients’ health. The IOM held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests.
Released: May 6, 2011
Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development - Workshop Summary Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The IOM held a workshop on July 22, 2010, to explore these issues and develop solutions.
Released: December 16, 2010